Covidien adds RFID technology to contrast delivery system
Covidien Imaging Solutions’ has released its contrast delivery system with radio-frequency identification (RFID) technology in the U.S.
The integration of RFID technology creates a system that is designed to aid in patient safety by helping to reduce the risk of medical errors, according to the St. Louis-based company.
Covidien said its contrast delivery system combines its unit-dose RFID-enabled Ultraject prefilled contrast media syringes with its RFID-enabled Optivantage DH power injector to provide.
The RFID-enabled system creates an interface between the contrast media syringe and the power injector that helps technologists to better ensure that each patient receives the prescribed concentration and programmed dose of a contrast media-related drug during a procedure, the company said.
The integration of RFID technology creates a system that is designed to aid in patient safety by helping to reduce the risk of medical errors, according to the St. Louis-based company.
Covidien said its contrast delivery system combines its unit-dose RFID-enabled Ultraject prefilled contrast media syringes with its RFID-enabled Optivantage DH power injector to provide.
The RFID-enabled system creates an interface between the contrast media syringe and the power injector that helps technologists to better ensure that each patient receives the prescribed concentration and programmed dose of a contrast media-related drug during a procedure, the company said.